Skip to main content
Journal cover image

Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.

Publication ,  Journal Article
Adjei, A; Kupper, RJ; Teuscher, NS; Wigal, S; Sallee, F; Childress, A; Kollins, SH; Greenhill, L
Published in: Clin Drug Investig
November 2014

OBJECTIVES: The objective of the study was to determine the relative bioavailability of an extended-release multilayer bead formulation of methylphenidate hydrochloride (MPH-MLR) 80 mg vs. methylphenidate immediate-release (IR; Ritalin(®)) tablets as single and multiple doses in the fed state. METHODS: A single-center, multiple-dose, randomized, open-label, two-period crossover study conducted in 26 healthy adults assigned to 4 days of once-daily MPH-MLR 80 mg or IR methylphenidate 25 mg three times daily. RESULTS: MPH-MLR 80 mg produced reproducible biphasic profiles of plasma methylphenidate concentrations characterized by a rapid initial peak, followed by a moderate decline reaching a plateau ~5 h post dose, then a gradual increase culminating in an attenuated second peak ~7 h post dose. Maximum concentration was lower for MPH-MLR 80 mg than IR methylphenidate 25 mg three times daily on day 1 (23.70 vs. 31.47 ng/mL); exposure was similar. The geometric mean ratios (MPH-MLR/IR methylphenidate [90 % CI]) of log-transformed area under the plasma drug concentration-time curve to the last measurable observation (day 1: 0.88 [84.75-91.80]; day 4: 0.84 [81.16-86.94]), and area under the plasma drug concentration extrapolated to infinity (day 1: 0.93 [88.57-97.28]; day 4: 0.88 [84.48-91.17]) were within the 80-125 % bioequivalence range. The mean ± SD MPH-MLR 80-mg capsule day 4 area under the plasma drug concentration vs. time curve from 0 to 4 h (74.5 ± 15.2 ng·h/mL) was greater than IR methylphenidate 25 mg three times daily (66.0 ± 17.4 ng·h/mL), confirming steady-state levels during the study period. All treatment regimens were safe and well tolerated. CONCLUSION: MPH-MLR 80-mg capsule once daily or IR methylphenidate 25 mg three times daily provides comparable maximum methylphenidate concentrations and systemic exposure in the fed state.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Drug Investig

DOI

EISSN

1179-1918

Publication Date

November 2014

Volume

34

Issue

11

Start / End Page

795 / 805

Location

New Zealand

Related Subject Headings

  • Young Adult
  • Tablets
  • Pharmacology & Pharmacy
  • Middle Aged
  • Methylphenidate
  • Male
  • Humans
  • Healthy Volunteers
  • Female
  • Drug Administration Schedule
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Adjei, A., Kupper, R. J., Teuscher, N. S., Wigal, S., Sallee, F., Childress, A., … Greenhill, L. (2014). Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers. Clin Drug Investig, 34(11), 795–805. https://doi.org/10.1007/s40261-014-0234-x
Adjei, Akwete, Robert J. Kupper, Nathan S. Teuscher, Sharon Wigal, Floyd Sallee, Ann Childress, Scott H. Kollins, and Laurence Greenhill. “Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.Clin Drug Investig 34, no. 11 (November 2014): 795–805. https://doi.org/10.1007/s40261-014-0234-x.
Adjei A, Kupper RJ, Teuscher NS, Wigal S, Sallee F, Childress A, et al. Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers. Clin Drug Investig. 2014 Nov;34(11):795–805.
Adjei, Akwete, et al. “Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.Clin Drug Investig, vol. 34, no. 11, Nov. 2014, pp. 795–805. Pubmed, doi:10.1007/s40261-014-0234-x.
Adjei A, Kupper RJ, Teuscher NS, Wigal S, Sallee F, Childress A, Kollins SH, Greenhill L. Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers. Clin Drug Investig. 2014 Nov;34(11):795–805.
Journal cover image

Published In

Clin Drug Investig

DOI

EISSN

1179-1918

Publication Date

November 2014

Volume

34

Issue

11

Start / End Page

795 / 805

Location

New Zealand

Related Subject Headings

  • Young Adult
  • Tablets
  • Pharmacology & Pharmacy
  • Middle Aged
  • Methylphenidate
  • Male
  • Humans
  • Healthy Volunteers
  • Female
  • Drug Administration Schedule